339 related articles for article (PubMed ID: 21404067)
1. The many faces of the contact pathway and their role in thrombosis.
Woodruff RS; Sullenger B; Becker RC
J Thromb Thrombolysis; 2011 Jul; 32(1):9-20. PubMed ID: 21404067
[TBL] [Abstract][Full Text] [Related]
2. Factor XI and contact activation as targets for antithrombotic therapy.
Gailani D; Bane CE; Gruber A
J Thromb Haemost; 2015 Aug; 13(8):1383-95. PubMed ID: 25976012
[TBL] [Abstract][Full Text] [Related]
3. Factor XI and XII as antithrombotic targets.
Müller F; Gailani D; Renné T
Curr Opin Hematol; 2011 Sep; 18(5):349-55. PubMed ID: 21730835
[TBL] [Abstract][Full Text] [Related]
4. The hemostatic role of factor XI.
Puy C; Rigg RA; McCarty OJ
Thromb Res; 2016 May; 141 Suppl 2(Suppl 2):S8-S11. PubMed ID: 27207433
[TBL] [Abstract][Full Text] [Related]
5. Coagulation factor XI as a novel target for antithrombotic treatment.
Löwenberg EC; Meijers JC; Monia BP; Levi M
J Thromb Haemost; 2010 Nov; 8(11):2349-57. PubMed ID: 20727068
[TBL] [Abstract][Full Text] [Related]
6. The rebirth of the contact pathway: a new therapeutic target.
Srivastava P; Gailani D
Curr Opin Hematol; 2020 Sep; 27(5):311-319. PubMed ID: 32740037
[TBL] [Abstract][Full Text] [Related]
7. Factor XI and factor XII as targets for new anticoagulants.
Weitz JI
Thromb Res; 2016 May; 141 Suppl 2():S40-5. PubMed ID: 27207423
[TBL] [Abstract][Full Text] [Related]
8. The Safety and Efficacy of Novel Agents Targeting Factors XI and XII in Early Phase Human Trials.
DeLoughery EP; Olson SR; Puy C; McCarty OJT; Shatzel JJ
Semin Thromb Hemost; 2019 Jul; 45(5):502-508. PubMed ID: 31216587
[TBL] [Abstract][Full Text] [Related]
9. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis.
Kleinschnitz C; Stoll G; Bendszus M; Schuh K; Pauer HU; Burfeind P; Renné C; Gailani D; Nieswandt B; Renné T
J Exp Med; 2006 Mar; 203(3):513-8. PubMed ID: 16533887
[TBL] [Abstract][Full Text] [Related]
10. [New perspective of anticoagulation in intensive care unit: basic and clinical advances in coagulation factor XII and XI inhibitors].
Wang R; Yang Z; Ma S; Zhu F
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Jan; 36(1):16-22. PubMed ID: 38404266
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic targeting of coagulation factors XII and XI by monoclonal antibodies reduces thrombosis in nitinol stents under flow.
Keeling NM; Wallisch M; Johnson J; Le HH; Vu HH; Jordan KR; Puy C; Tucker EI; Nguyen KP; McCarty OJT; Aslan JE; Hinds MT; Anderson DEJ
J Thromb Haemost; 2024 May; 22(5):1433-1446. PubMed ID: 38331196
[TBL] [Abstract][Full Text] [Related]
12. Coagulation factor XI improves host defence during murine pneumonia-derived sepsis independent of factor XII activation.
Stroo I; Zeerleder S; Ding C; Luken BM; Roelofs JJTH; de Boer OJ; Meijers JCM; Castellino FJ; van 't Veer C; van der Poll T
Thromb Haemost; 2017 Jul; 117(8):1601-1614. PubMed ID: 28492700
[TBL] [Abstract][Full Text] [Related]
13. Epidemiologic and clinical data linking factors XI and XII to thrombosis.
Key NS
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):66-70. PubMed ID: 25696836
[TBL] [Abstract][Full Text] [Related]
14. Factor XII inhibition reduces thrombus formation in a primate thrombosis model.
Matafonov A; Leung PY; Gailani AE; Grach SL; Puy C; Cheng Q; Sun MF; McCarty OJ; Tucker EI; Kataoka H; Renné T; Morrissey JH; Gruber A; Gailani D
Blood; 2014 Mar; 123(11):1739-46. PubMed ID: 24408325
[TBL] [Abstract][Full Text] [Related]
15. Regulation of blood coagulation factors XI and XII in patients with acute and chronic cerebrovascular disease: a case-control study.
Kraft P; Drechsler C; Gunreben I; Heuschmann PU; Kleinschnitz C
Cerebrovasc Dis; 2014; 38(5):337-43. PubMed ID: 25427539
[TBL] [Abstract][Full Text] [Related]
16. Coagulation factor XII in thrombosis and inflammation.
Maas C; Renné T
Blood; 2018 Apr; 131(17):1903-1909. PubMed ID: 29483100
[TBL] [Abstract][Full Text] [Related]
17. Obesity-related derangements of coagulation and fibrinolysis: a study of obesity-discordant monozygotic twin pairs.
Kaye SM; Pietiläinen KH; Kotronen A; Joutsi-Korhonen L; Kaprio J; Yki-Järvinen H; Silveira A; Hamsten A; Lassila R; Rissanen A
Obesity (Silver Spring); 2012 Jan; 20(1):88-94. PubMed ID: 21959347
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic pathway of coagulation and arterial thrombosis.
Gailani D; Renné T
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770
[TBL] [Abstract][Full Text] [Related]
19. Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI.
Tucker EI; Marzec UM; White TC; Hurst S; Rugonyi S; McCarty OJ; Gailani D; Gruber A; Hanson SR
Blood; 2009 Jan; 113(4):936-44. PubMed ID: 18945968
[TBL] [Abstract][Full Text] [Related]
20. Factor XI: hemostasis, thrombosis, and antithrombosis.
He R; Chen D; He S
Thromb Res; 2012 May; 129(5):541-50. PubMed ID: 22197449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
